Symbol="KYMR"
AssetType="Common Stock"
Name="Kymera Therapeutics Inc"
Description="Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down disease-causing proteins by harnessing the body's own natural protein breakdown system. The company is headquartered in Watertown, Massachusetts."
CIK="1815442"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="300 TECHNOLOGY SQUARE, 2ND FLOOR, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1246085000"
EBITDA="-167680000"
PERatio="None"
PEGRatio="None"
BookValue="8.43"
DividendPerShare="0"
DividendYield="0"
EPS="-2.85"
RevenuePerShareTTM="0.84"
ProfitMargin="0"
OperatingMarginTTM="-3.635"
ReturnOnAssetsTTM="-0.18"
ReturnOnEquityTTM="-0.357"
RevenueTTM="46670000"
GrossProfitTTM="-117422000"
DilutedEPSTTM="-2.85"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.016"
AnalystTargetPrice="53.72"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="33.3"
PriceToBookRatio="3.168"
EVToRevenue="25.24"
EVToEBITDA="-7.69"
Beta="1.51"
num_52WeekHigh="39.85"
num_52WeekLow="18.84"
num_50DayMovingAverage="26.59"
num_200DayMovingAverage="28.73"
SharesOutstanding="55308000"
DividendDate="None"
ExDividendDate="None"
symbol="KYMR"
open="22.97"
high="23.39"
low="22.51"
price="22.82"
volume="338822.00"
latest_trading_day="2023-07-12"
previous_close="22.53"
change="0.29"
change_percent="1.2872%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="65"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="35"
Volume_recent_avg="504873"
Change_recent_avg="-0.1"
Delta_recent_avg="1.57"
Variance_recent_avg="0.78"
Change_ratio_recent_avg="-0.41"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="35"
Aroon_momentum_negative="65"
image_negative_thumbnail_id_1="137"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0039.jpeg"
image_negative_thumbnail_id_2="161"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_neutral_thumbnail_id_1="548"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_neutral_thumbnail_id_2="565"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_positive_thumbnail_id_1="1014"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0176.jpeg"
image_positive_thumbnail_id_2="679"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0029.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
